COSMIX Strengthens Its Technology to Identify or Improve Peptide Products.Business Editors/Health/Medical Writers BIOWIRE2K BRAUNSCHWEIG, Germany--(BUSINESS WIRE)--April 5, 2004 COSMIX molecular biologicals GmbH (COSMIX) today announced that it had acquired non-exclusive rights to an mRNA-peptide display technology useful for the discovery of peptides with high affinity for selected targets. "We are more than pleased," said Dr. Peter Wagner The name Peter Wagner can refer to several persons:
The technology (sometimes referred to as PROfusion(TM) Technology) was licensed from Phylos, Inc. by Gryphon Therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. , an affiliate of COSMIX. This technology has a proven track record of identifying peptides specific for many different targets, including proteins, carbohydrates Carbohydrates Compounds, such as cellulose, sugar, and starch, that contain only carbon, hydrogen, and oxygen, and are a major part of the diets of people and other animals. Mentioned in: Laxatives carbohydrates, n. , nucleic acids Nucleic acids The cellular molecules DNA and RNA that act as coded instructions for the production of proteins and are copied for transmission of inherited traits. , small chemical compounds, and cells. The technology can also be applied to improve the stability (temperature, pH, proteolytic pro·te·o·lyt·ic adj. Relating to, characterized by, or promoting proteolysis. proteolytic (pro″teolit´ik), adj degradation, etc.), affinity and specificity of peptides. The COSMIX team has been expanded to include scientists experienced in the successful application of this technology. The mRNA-peptide display technology will be used as an alternative to the Company's established phagemid display approach to peptide identification. This allows COSMIX' scientists to select the technique best adapted to a given target. Further, COSMIX may apply its propriety pro·pri·e·ty n. pl. pro·pri·e·ties 1. The quality of being proper; appropriateness. 2. Conformity to prevailing customs and usages. 3. proprieties The usages and customs of polite society. Cosmix-plexing(R) technology to optimize characteristics of peptides. This significantly increases the likelihood that the development of peptide products will be successful. COSMIX is a biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. company focused on the identification and improvement of peptides for applications in healthcare, research, and industry. The Company's strong technology platforms enable the generation of peptides with high affinity and optimal characteristics for a wide range of applications. Based in Braunschweig, Germany, COSMIX employs its technology for the development of its own products, and to provide solutions for its partners throughout the world. COSMIX is a wholly-owned subsidiary of Gryphon Therapeutics, Inc. The trademark PROfusion(TM) Technology is owned by Phylos, Inc. or its successor. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion